Injectable hydrogel biomaterial

Tokyo, Japan

Gellycle is a bio startup originating from the University of Tokyo, established in 2018 with the goal of revolutionizing medicine using Tetra-gel which is the world's only homogeneous gel. By using Tetragel technology, we create various medical and industrial products such as hemostatic agents, anti-adhesion materials, nerve regeneration materials, ophthalmic surgery aids, soil water retention materials for agriculture, and new electrode components. <Current Pipelines that we are seeking for> •Controlled Drug Delivery (AAV, etc.) •Iontophoresis for Type 1 Diabetes •Tendon Regeneration & Anti-Adhesion Material •Fat, Bone & Nerve Regeneration Material •Hydrorelease & Ophthalmic Viscoelastic Device •Artificial Ligament and Gel Thread •Dental application (Gum regeneration, wound healing) •Wound Dressing or New Culture Medium (3D) • Eco-Friendly Super Absorbent Polymer <Achievement> •Winner of the ICC Summit KYOTO 2021 Real Tech Catapult. •University Venture Award 2023 University Venture Award Special Prize. •Selected for Berkeley SkyDeck, the world's top accelerator.